Global drugmakers lose positions in Russia due to reduced advertising budgets

Sales of Russian drugs grew in 2022 due to an increase of advertising budgets and a decline of the share of foreign drugs, reports The Pharma Letter’s local correspondent.

For the first time, six Russian drugmakers have entered the top 10 largest pharmaceutical companies in Russia in terms of investment in television advertising in 2022.

At the same time Western pharmaceutical companies, many of which announced the suspension of advertising activities in Russia after the beginning of the military conflict in Ukraine, were replaced by Russian ones.